Literature DB >> 27862906

Characterization of pain, disability, and psychological burden in Marfan syndrome.

Traci J Speed1, Vani A Mathur2, Matthew Hand1, Bryt Christensen3, Paul D Sponseller4, Kayode A Williams3, Claudia M Campbell1.   

Abstract

The clinical manifestations of Marfan syndrome frequently cause pain. This study aimed to characterize pain in a cohort of adults with Marfan syndrome and investigate demographic, physical, and psychological factors associated with pain and pain-related disability. Two hundred and forty-five participants (73% female, 89% non-Hispanic white, 90% North American) completed an online questionnaire assessing clinical features of Marfan syndrome, pain severity, pain-related disability, physical and mental health, depressive symptoms, pain catastrophizing, and insomnia. Eighty-nine percent of respondents reported having pain with 28% of individuals reporting pain as a presenting symptom of Marfan syndrome. Almost half of individuals reported that pain has spread from its initial site. Participants in our study reported poor physical and mental health functioning, moderate pain-related disability, and mild levels of depressive symptoms, sleep disturbances, and pain catastrophizing. Those who identified pain as an initial symptom of Marfan syndrome and those who reported that pain had spread from its initial site reported greater psychological burden compared with those without pain as an initial symptom or pain spreading. Physical health is the largest predictor of pain severity and pain-related disability. While pain catastrophizing and worse mental health functioning are significant correlates of pain severity and pain-related disability, respectively. Pain is a significant and persistent problem in Marfan syndrome and is associated with profound disability and psychological burden. Further studies are indicated to better characterize the directionality of pain, pain-related disability, and psychological burden in Marfan syndrome.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  Marfan syndrome; catastrophizing; pain; quality of life; questionnaire

Mesh:

Year:  2016        PMID: 27862906      PMCID: PMC6059361          DOI: 10.1002/ajmg.a.38051

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  49 in total

1.  Ethnic Group Differences in the Outcomes of Multidisciplinary Pain Treatment.

Authors:  Brian Merry; Claudia M Campbell; Luis F Buenaver; Lynanne McGuire; Jennifer A Haythornthwaite; Daniel M Doleys; Robert R Edwards
Journal:  J Musculoskelet Pain       Date:  2011-01

2.  Increasing the reliability and validity of pain intensity measurement in chronic pain patients.

Authors:  M P Jensen; C A McFarland
Journal:  Pain       Date:  1993-11       Impact factor: 6.961

3.  Work participation in adults with Marfan syndrome: Demographic characteristics, MFS related health symptoms, chronic pain, and fatigue.

Authors:  Gry Velvin; Trine Bathen; Svend Rand-Hendriksen; Amy Østertun Geirdal
Journal:  Am J Med Genet A       Date:  2015-09-30       Impact factor: 2.802

4.  The role of depression and catastrophizing in musculoskeletal pain.

Authors:  Steven J Linton; Michael K Nicholas; Shane MacDonald; Katja Boersma; Sofia Bergbom; Chris Maher; Kathy Refshauge
Journal:  Eur J Pain       Date:  2010-09-29       Impact factor: 3.931

Review 5.  Systematic review of the psychosocial aspects of living with Marfan syndrome.

Authors:  G Velvin; T Bathen; S Rand-Hendriksen; A Ø Geirdal
Journal:  Clin Genet       Date:  2014-06-04       Impact factor: 4.438

6.  The Marfan syndrome: joint and skin manifestations are prevalent and correlated.

Authors:  R Grahame; R E Pyeritz
Journal:  Br J Rheumatol       Date:  1995-02

Review 7.  Marfan syndrome: clinical diagnosis and management.

Authors:  John C S Dean
Journal:  Eur J Hum Genet       Date:  2007-05-09       Impact factor: 4.246

8.  Ten-year clinical and imaging follow-up of dural ectasia in adults with Marfan syndrome.

Authors:  Addisu Mesfin; Nicholas U Ahn; John A Carrino; Paul D Sponseller
Journal:  Spine J       Date:  2012-12-06       Impact factor: 4.166

Review 9.  Mutations in the human gene for fibrillin-1 (FBN1) in the Marfan syndrome and related disorders.

Authors:  H C Dietz; R E Pyeritz
Journal:  Hum Mol Genet       Date:  1995       Impact factor: 6.150

10.  Disuse and physical deconditioning in the first year after the onset of back pain.

Authors:  Eric J Bousema; Jeanine A Verbunt; Henk A M Seelen; Johan W S Vlaeyen; André J Knottnerus
Journal:  Pain       Date:  2007-04-30       Impact factor: 6.961

View more
  17 in total

Review 1.  A Review of Psychosocial Factors of Marfan Syndrome: Adolescents, Adults, Families, and Providers.

Authors:  Cory Nielsen; Ileana Ratiu; Mitra Esfandiarei; Angela Chen; Elif Seda Selamet Tierney
Journal:  J Pediatr Genet       Date:  2019-07-25

2.  The transition of pediatric Marfan patients to adult care: a challenge and its risks.

Authors:  Veronika C Stark; Katrin Doering; Yskert von Kodolitsch; Rainer Kozlik-Feldmann; Götz C Mueller; Jakob Olfe; Meike Rybczynski; Helke Schueler; Thomas S Mir
Journal:  Cardiovasc Diagn Ther       Date:  2018-12

3.  Health-Related Quality of Life in Children and Young Adults with Marfan Syndrome.

Authors:  Jill C Handisides; Danielle Hollenbeck-Pringle; Karen Uzark; Felicia L Trachtenberg; Victoria L Pemberton; Teresa W Atz; Timothy J Bradley; Elizabeth Cappella; Sylvia De Nobele; Georgeann Keh-Teng Groh; Michelle S Hamstra; Rosalind Korsin; Jami C Levine; Bergen Lindauer; Aimee Liou; Meghan K Mac Neal; Larry W Markham; Tonia Morrison; Kathleen A Mussatto; Aaron K Olson; Mary Ella M Pierpont; Reed E Pyeritz; Elizabeth A Radojewski; Mary J Roman; Mingfen Xu; Ronald V Lacro
Journal:  J Pediatr       Date:  2018-09-27       Impact factor: 4.406

Review 4.  Left to themselves: Time to target chronic pain in childhood rare diseases.

Authors:  Christine B Sieberg; Alyssa Lebel; Erin Silliman; Scott Holmes; David Borsook; Igor Elman
Journal:  Neurosci Biobehav Rev       Date:  2021-03-24       Impact factor: 8.989

5.  Quality of life in patients with Marfan syndrome: a cross-sectional study of 102 adult patients.

Authors:  Caroline Andonian; Sebastian Freilinger; Stefan Achenbach; Peter Ewert; Ulrike Gundlach; Harald Kaemmerer; Nicole Nagdyman; Rhoia Clara Neidenbach; Lars Pieper; Jörg Schelling; Michael Weyand; Jürgen Beckmann
Journal:  Cardiovasc Diagn Ther       Date:  2021-04

Review 6.  Marfan syndrome.

Authors:  Dianna M Milewicz; Alan C Braverman; Julie De Backer; Shaine A Morris; Catherine Boileau; Irene H Maumenee; Guillaume Jondeau; Arturo Evangelista; Reed E Pyeritz
Journal:  Nat Rev Dis Primers       Date:  2021-09-02       Impact factor: 65.038

7.  Inpatient rehabilitation for adult patients with Marfan syndrome: an observational pilot study.

Authors:  Dieter Benninghoven; Denise Hamann; Yskert von Kodolitsch; Meike Rybczynski; Julia Lechinger; Friedrich Schroeder; Marina Vogler; Eike Hoberg
Journal:  Orphanet J Rare Dis       Date:  2017-07-12       Impact factor: 4.123

8.  Heritable Connective Tissue Disorders in Childhood: Increased Fatigue, Pain, Disability and Decreased General Health.

Authors:  Jessica Warnink-Kavelaars; Lisanne E de Koning; Lies Rombaut; Mattijs W Alsem; Leonie A Menke; Jaap Oosterlaan; Annemieke I Buizer; Raoul H H Engelbert
Journal:  Genes (Basel)       Date:  2021-05-28       Impact factor: 4.096

9.  Marfan syndrome in adolescence: adolescents' perspectives on (physical) functioning, disability, contextual factors and support needs.

Authors:  Jessica Warnink-Kavelaars; Anita Beelen; Tine M H J Goedhart; Lisanne E de Koning; Frans Nollet; Mattijs W Alsem; Leonie A Menke; Raoul H H Engelbert
Journal:  Eur J Pediatr       Date:  2019-10-16       Impact factor: 3.183

Review 10.  The Molecular Genetics of Marfan Syndrome.

Authors:  Qiu Du; Dingding Zhang; Yue Zhuang; Qiongrong Xia; Taishen Wen; Haiping Jia
Journal:  Int J Med Sci       Date:  2021-05-27       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.